{"id":3614,"date":"2019-09-02T09:46:47","date_gmt":"2019-09-02T09:46:47","guid":{"rendered":"https:\/\/lynxee.consulting\/?p=3614"},"modified":"2024-10-01T13:04:00","modified_gmt":"2024-10-01T13:04:00","slug":"france-anses-withdrawal-epoxiconazole_based-products","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/","title":{"rendered":"FRANCE: Withdrawal of epoxiconazole-based products"},"content":{"rendered":"<p style=\"text-align: justify;\">In Anses Opinion dated 19 April 2019, Anses concluded that <strong>Epoxiconazole<\/strong> is an endocrine disruptor for humans and non-target organisms. Further to this evaluation, Anses has withdrawn 24 authorisations and 52 parallel trade permits for plant protection products containing this active substance on 30 July 2019.<\/p>\n<p>&nbsp;<\/p>\n<p>The <strong>end of sales and distribution<\/strong> is set on <strong>30.11.2019<\/strong>.<\/p>\n<p>The <strong>end of use of the stocks<\/strong> of products is set on <strong>30.07.2020<\/strong>.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>To download:<\/strong><\/p>\n<p><a href=\"https:\/\/ephy.anses.fr\/var\/default\/files\/liste_retraits_epoxiconazole.xls\" target=\"_blank\" rel=\"noopener noreferrer\">List of withdrawal of products based on epoxiconazole<\/a> (in French)<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our previous articles:<\/strong><\/p>\n<p><a href=\"https:\/\/lynxee.consulting\/en\/france-anses-epoxiconazole-based-products-ban\/\" target=\"_blank\" rel=\"noopener noreferrer\">FRANCE \u2013 ANSES: Epoxiconazole-based products ban<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Lynxee consulting<\/strong>\u2019s team is at your disposal to answer your questions.<\/p>\n<p><strong>Contact us! <\/strong><a href=\"https:\/\/lynxee.consulting\/en\/contact\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/lynxee.consulting\/en\/contact\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6>Photo credit: kangbch\/pixabay<\/h6>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this evaluation, Anses has<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":5,"featured_media":3611,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[64,108,192],"class_list":["post-3614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-anses-en","tag-ban-of-pesticides","tag-interdiction-pesticides-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FRANCE: Withdrawal of epoxiconazole-based products - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FRANCE: Withdrawal of epoxiconazole-based products - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-02T09:46:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-01T13:04:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/09\/barley-field-1684052_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karine Mavet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karine Mavet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/\"},\"author\":{\"name\":\"Karine Mavet\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/a2a6161ec6591c6ae990f836d8ae4f63\"},\"headline\":\"FRANCE: Withdrawal of epoxiconazole-based products\",\"datePublished\":\"2019-09-02T09:46:47+00:00\",\"dateModified\":\"2024-10-01T13:04:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/\"},\"wordCount\":116,\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/barley-field-1684052_1920.jpg\",\"keywords\":[\"ANSES\",\"ban of pesticides\",\"interdiction pesticides\"],\"articleSection\":[\"Regulation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/\",\"name\":\"FRANCE: Withdrawal of epoxiconazole-based products - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/barley-field-1684052_1920.jpg\",\"datePublished\":\"2019-09-02T09:46:47+00:00\",\"dateModified\":\"2024-10-01T13:04:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/a2a6161ec6591c6ae990f836d8ae4f63\"},\"description\":\"In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/barley-field-1684052_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/barley-field-1684052_1920.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-anses-withdrawal-epoxiconazole_based-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FRANCE: Withdrawal of epoxiconazole-based products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lynxee.consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/a2a6161ec6591c6ae990f836d8ae4f63\",\"name\":\"Karine Mavet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/05\\\/karine-96x96.jpg\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/05\\\/karine-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/05\\\/karine-96x96.jpg\",\"caption\":\"Karine Mavet\"},\"sameAs\":[\"https:\\\/\\\/lynxee.consulting\"],\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/author\\\/karine\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FRANCE: Withdrawal of epoxiconazole-based products - Lynxee consulting","description":"In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/","og_locale":"en_US","og_type":"article","og_title":"FRANCE: Withdrawal of epoxiconazole-based products - Lynxee consulting","og_description":"In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this","og_url":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/","og_site_name":"Lynxee consulting","article_published_time":"2019-09-02T09:46:47+00:00","article_modified_time":"2024-10-01T13:04:00+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/09\/barley-field-1684052_1920.jpg","type":"image\/jpeg"}],"author":"Karine Mavet","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karine Mavet","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#article","isPartOf":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/"},"author":{"name":"Karine Mavet","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63"},"headline":"FRANCE: Withdrawal of epoxiconazole-based products","datePublished":"2019-09-02T09:46:47+00:00","dateModified":"2024-10-01T13:04:00+00:00","mainEntityOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/"},"wordCount":116,"image":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/09\/barley-field-1684052_1920.jpg","keywords":["ANSES","ban of pesticides","interdiction pesticides"],"articleSection":["Regulation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/","url":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/","name":"FRANCE: Withdrawal of epoxiconazole-based products - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/09\/barley-field-1684052_1920.jpg","datePublished":"2019-09-02T09:46:47+00:00","dateModified":"2024-10-01T13:04:00+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63"},"description":"In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/09\/barley-field-1684052_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/09\/barley-field-1684052_1920.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/france-anses-withdrawal-epoxiconazole_based-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"FRANCE: Withdrawal of epoxiconazole-based products"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63","name":"Karine Mavet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","caption":"Karine Mavet"},"sameAs":["https:\/\/lynxee.consulting"],"url":"https:\/\/lynxee.consulting\/en\/author\/karine\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/3614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=3614"}],"version-history":[{"count":3,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/3614\/revisions"}],"predecessor-version":[{"id":7463,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/3614\/revisions\/7463"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/3611"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=3614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=3614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=3614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}